Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$232.72 - $256.47 $4.81 Million - $5.3 Million
-20,683 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$232.65 - $254.58 $14,656 - $16,038
-63 Reduced 0.3%
20,683 $5.03 Million
Q1 2021

May 14, 2021

SELL
$232.09 - $256.88 $327,711 - $362,714
-1,412 Reduced 6.37%
20,746 $5.04 Million
Q4 2020

Feb 12, 2021

BUY
$221.92 - $245.94 $235,013 - $260,450
1,059 Added 5.02%
22,158 $5.54 Million
Q3 2020

Nov 13, 2020

SELL
$215.77 - $276.76 $1.88 Million - $2.42 Million
-8,732 Reduced 29.27%
21,099 $4.91 Million
Q2 2020

Aug 13, 2020

SELL
$219.9 - $263.41 $167,563 - $200,718
-762 Reduced 2.49%
29,831 $7.14 Million
Q1 2020

May 14, 2020

BUY
$195.69 - $279.01 $1.06 Million - $1.52 Million
5,439 Added 21.62%
30,593 $7.03 Million
Q4 2019

Feb 13, 2020

SELL
$236.45 - $266.82 $4.84 Million - $5.46 Million
-20,452 Reduced 44.84%
25,154 $6.84 Million
Q2 2019

Aug 13, 2019

BUY
$217.4 - $246.08 $1.02 Million - $1.15 Million
4,677 Added 11.43%
45,606 $11.5 Million
Q1 2019

Apr 11, 2019

BUY
$206.05 - $248.17 $1.96 Million - $2.36 Million
9,517 Added 30.3%
40,929 $10.2 Million
Q4 2018

Jan 22, 2019

BUY
$204.73 - $257.93 $795,376 - $1 Million
3,885 Added 14.11%
31,412 $7.08 Million
Q3 2018

Oct 29, 2018

BUY
$233.07 - $256.0 $309,983 - $340,480
1,330 Added 5.08%
27,527 $7.19 Million
Q2 2018

Aug 13, 2018

BUY
$208.1 - $233.85 $48,487 - $54,487
233 Added 0.9%
26,197 $6.29 Million
Q1 2018

Apr 30, 2018

BUY
$205.46 - $240.27 $656,239 - $767,422
3,194 Added 14.03%
25,964 $7.34 Million
Q4 2017

Feb 14, 2018

BUY
$189.0 - $222.64 $4.3 Million - $5.07 Million
22,770
22,770 $4.87 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Bell Asset Management LTD Portfolio

Follow Bell Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bell Asset Management LTD with notifications on news.